Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ligands derived from receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases

Use of ligands derived from receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases

US Patent 12352761 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
Use of receptor-binding domain derived from bovine leukemia virus for the diagno2023
In vitro assays for assessing cell aging2021
Receptor binding ligands, their use in the detection of cells with biological in2017
Receptor binding ligands, their use in the detection of cells with biological in2017
GLUT-1 as a receptor for HTLV envelopes and its uses2017
GLUT-1 as a receptor for HTLV envelopes and its uses2017